Synthetic biology company, Twist Bioscience Corporation, has established itself as a leading manufacturer and retailer of synthetic DNA-based products. The company boasts a DNA synthesis platform which endeavors to create synthetic DNA by means of writing DNA on a silicon chip. This platform has allowed Twist Bioscience Corporation to offer a range of synthetic DNA-based products such as synthetic genes, sample preparation tools, antibody libraries for drug discovery and development, and DNA which can be used as a digital data storage solution. Collaborations with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop revolutionary sequencing tools, further highlight Twist Bioscience Corporation's commitment to innovation. Additionally, through a research collaboration with Boehringer Ingelheim International GmbH utilizing proprietary antibody libraries, the company aims to discover therapeutic antibodies against multiple targets. Since its incorporation in 2013, the South San Francisco, California-based company has cemented its position as an industry leader in the emerging field of synthetic biology.
Twist Bioscience's ticker is TWST
The company's shares trade on the NASDAQ stock exchange
They are based in South San Francisco, California
There are 201-500 employees working at Twist Bioscience
It is twistbioscience.com
Twist Bioscience is in the Healthcare sector
Twist Bioscience is in the Biotechnology industry
The following five companies are Twist Bioscience's industry peers: